Frederic J. Kaye

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy”.

EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy

Science(2004)10.1126/science.1099314

N/A

1.4DataRank · unranked

9384 citations

Pasi A. Jänne, Jeffrey C. Lee, Sean Tracy, Heidi Greulich, Anthony Philippakis +13 more

The landscape of somatic copy-number alteration across human cancers

Nature(2010)10.1038/nature08822

N/A

1.2DataRank · unranked

4101 citations

Craig H. Mermel, Dale A. Porter, Guo Wei, Soumya Raychaudhuri, Jerry Donovan +61 more

BCL-XL PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRASG12C-mutated cancers

Journal of Hematology & Oncology(2022)10.1186/s13045-022-01241-3

N/A

0.621DataRank · unranked

62 citations

J Wiegand, Peiyi Zhang, Wanyi Hu, Dinesh Thummuri, Vivekananda Budamagunta +9 more

TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background

Oncogene(2023)10.1038/s41388-023-02694-7

N/A

0.505DataRank · unranked

28 citations

Akbar Nawab, Peter Dib, Sandra Burkett, Xiaoping Luo, Michael Feely +5 more

Targeting Notch and EGFR signaling in human mucoepidermoid carcinoma

Signal Transduction and Targeted Therapy(2021)10.1038/s41392-020-00388-0

N/A

0.494DataRank · unranked

26 citations

Zirong Chen, Xin Zhou, Rongqiang Yang, Mu Yu, Jianrong Lu +3 more

PROTAC-mediated dual degradation of BCL-xL and BCL-2 is a highly effective therapeutic strategy in small-cell lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.27.582353

N/A

0.312DataRank · unranked

7 citations

Lin Cao, J Wiegand, Peiyi Zhang, Maria Zajac‐Kaye, Frederic J. Kaye +3 more

Proof-of-Concept of an Integrated Yoga and Psychological Intervention in Mitigating Distress Among Diverse Women With Gynecologic, Gastrointestinal, and Thoracic Cancers

Integrative Cancer Therapies(2024)10.1177/15347354241283113

N/A

0.301DataRank · unranked

5 citations

Elizabeth L. Kacel, Kelsey C. Bacharz, Adaixa Padrón Wilborn, Sonia Mesa, Halle T. McCracken +7 more

Co-targeting BCL-X L and MCL-1 with DT2216 and AZD8055 synergistically inhibits small-cell lung cancer growth without causing on-target toxicities in mice

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.09.12.507616

N/A

0DataRank · unranked

0 citations

Patrick Kellish, Nick Connis, Dinesh Thummuri, J Wiegand, Peiyi Zhang +14 more

Co-targeting BCL-XL and MCL-1 with DT2216 and AZD8055 synergistically inhibit small-cell lung cancer growth without causing on-target toxicities in mice

Cell Death Discovery(2023)10.1038/s41420-022-01296-8

N/A

0DataRank · unranked

43 citations

Patrick Kellish, Nick Connis, Dinesh Thummuri, J Wiegand, Peiyi Zhang +14 more

PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer

Cells(2024)10.3390/cells13060528

N/A

0DataRank · unranked

29 citations

Lin Cao, J Wiegand, Peiyi Zhang, Maria Zajac‐Kaye, Frederic J. Kaye +3 more

The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma

JCI Insight(2021)10.1172/jci.insight.139497

N/A

0DataRank · unranked

69 citations

Wei Ni, Jian‐Liang Li, Shuibin Lin, Xin Zhou, Yuping Sun +10 more

Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated vulnerability

Biomaterials(2025)10.1016/j.biomaterials.2025.123920

N/A

0DataRank · unranked

1 citations

Yinong Chen, Chenyu Liang, Om Narayan, Chase Stallings, Mu Yu +29 more

Dependency of LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.01.09.425982

N/A

0DataRank · unranked

0 citations

Jennifer W. Li, Zirong Chen, Wei Ni, Xuehui Li, Rongqiang Yang +7 more

PROTAC therapy as a new targeted therapy for lung cancer

Molecular Therapy(2022)10.1016/j.ymthe.2022.11.011

N/A

0DataRank · unranked

83 citations

Guangrong Zheng, Frederic J. Kaye, Lizi Wu, Jennifer W. Li

The landscape of somatic copy-number alteration across human cancers

PMC(2020)10.17615/gvhn-9a16

N/A

0DataRank · unranked

0 citations

Michael S. Lawrence, Ted Liefeld, Michael R. Reich, Rameen Beroukhim, Reid M. Pinchback +27 more